Clinical Trials Browser

Phase 3 × Hematologic Neoplasms × BNT162 Vaccine × Clear all

NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Phase 3 Unknown

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms